And the results showed that the BCMA expression of MM patients was moderately positively correlated with the percentage of plasma cells in their bone marrow (P=0.000, r=0.471), which is in line with clinical practice. This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.